by Gabriel Levitt, Vice President, PharmacyChecker.com and Margaret Rode, PharmacyChecker.com | Aug 31, 2011 | Drug Prices, Healthcare Reform
A new report by the Commonwealth Fund, from their 2010 Biennial Health Insurance Survey, shows that 48 million Americans, ages 19-64, did not fill a prescription due to cost in 2010, up from 29 million in 2001 – a 66% increase. The study includes both insured and uninsured Americans but does not include children and seniors. The study indicates that the recession has greatly exacerbated the national crisis of prescription non-adherence (skipping medications), as nine out of 16 million Americans who have lost their job have also lost their health insurance.
It is difficult to estimate the sickness and even death that has resulted from so many millions of Americans not taking their prescribed medication due to cost. As evidenced by the new report, the situation is particularly dire for uninsured Americans with chronic medical conditions, as 27 million “skipped doses or did not fill a prescription for their condition because of the cost.” (more…)
Tagged with: Affordable Care Act, Biennial Health Insurance Survey, chronic, Commonwealth Fund, consumer guide, health insurance, Medicare, Medicare Drug Plans, prescription costs, skipping medicine, United States
by PharmacyChecker.com | Apr 8, 2011 | Drug Prices
We don’t mean to sound like a broken record, but more reports keep coming out informing us, and hopefully our elected officials, too, that people are not taking their medication due to cost. Most recently it is the Mayo Clinic.
Based on a study of 209 patients prescribed heart medications, researchers found that among patients who did a poor job following prescriptions, financial concern was the main reason: 46 percent reported that they had stopped taking statins or not filled a prescription because of cost, and 23 percent acknowledged skipping doses to save money.
If there was ever ambiguity about whether high drug prices are a major threat to the public health, there is no longer. Data gathered by the U.S. Center for Disease Control, the National Consumer’s League, and Harvard School of Public Health, and, now, from the Mayo Clinic proves the point. We’ve dedicated time and effort in finding solutions to this health emergency. Our Consumer Guide can help Americans alleviate this burden and our advocacy initiative provides them with a platform to speak up to their elected officials.
Tagged with: Advocacy, Center for Disease Control, consumer guide, Harvard School of Public Health, Mayo Clinic, medication, National Consumer's League, prescription abandonment, skipping medicine, United States